Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 01/03/18 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/18 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 01/11/18 |
Yong Dai
PRN | Corporate Officer/Principal | 53 | 01/02/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 34 248 033 | 29 795 530 ( 87,00 %) | 0 | 87,00 % |
Coordinate società
Prevail Therapeutics, Inc.
430 East 29th Street Suite 1520
10016, New York
+
http://www.prevailtherapeutics.com![Indirizzo Prevail Therapeutics Inc.(PRVL)](https://cdn.zonebourse.com/static/address/60037660.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,44% | 122 Mrd | |
+18,94% | 113 Mrd | |
+18,81% | 26,22 Mrd | |
-25,37% | 19,01 Mrd | |
-19,77% | 15,71 Mrd | |
-20,20% | 15,22 Mrd | |
-47,37% | 14,72 Mrd | |
+59,91% | 14,58 Mrd | |
+4,35% | 13,84 Mrd |